Protocol I4V-MC-JADW: Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Pat

Printer-friendly versionSend by emailPDF version

Name

Lilly USA, LLC

Anticipated Amount

85 185.00

Activity Type

Clinical Trial

Award Type

Contract

Date

October 1, 2012 to May 30, 2015

Award Number

006021-00001

Sponsor Award Number

14V-MC-JADW

Award Contacts

Name

Lisse,Jeffrey R

Title

Principal Investigator

Unit

Arthritis Center-Research

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona